PEAK trial first ever study to demonstrate statistical significance over an active comparator in GIST patients, with bezuclastinib plus ...
Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions. Dr. Breelyn Wilky, an associate professor of ...
Hoth Therapeutics Inc. has released preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors (GIST).
BLOOMINGTON, Minn.--The GIST Cancer Research Fundraiser is Friday, August 4 at the Knights of Columbus from 7:00 p.m.-10:00 p.m. Proceeds provide support to those with Gastro Intestinal Stromal Tumors ...
GSK plc (NYSE:GSK) agreed to acquire IDRx, Inc., a biopharmaceutical company focused on precision therapeutics for gastrointestinal stromal tumors (GIST), for $1 billion. Under the agreement, GSK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results